Bcl-2 Overexpression Improves Survival and Efficacy of Neural Stem Cell-Mediated Enzyme Prodrug Therapy
Tumor-tropic neural stem cells (NSCs) can be engineered to localize gene therapies to invasive brain tumors. However, like other stem cell-based therapies, survival of therapeutic NSCs after transplantation is currently suboptimal. One approach to prolonging cell survival is to transiently overexpre...
Saved in:
| Main Authors: | Rachael Mooney, Asma Abdul Majid, Daniel Mota, Adam He, Soraya Aramburo, Linda Flores, Jennifer Covello-Batalla, Diana Machado, Joanna Gonzaga, Karen S. Aboody |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2018/7047496 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoparticle delivery of a prodrug-activating bacterial enzyme leads to anti-tumor responses
by: Sebastian G. Huayamares, et al.
Published: (2025-04-01) -
Virus-directed enzyme prodrug therapy and the assessment of the cytotoxic impact of some benzimidazole derivatives
by: Michał Szewczuk, et al.
Published: (2017-07-01) -
Creation of anthracycline prodrug
by: A. N. Tevyashova
Published: (2014-12-01) -
Advancing targeted therapy for colorectal cancer: harnessing ligand-directed enzyme prodrug therapy for highly specific interventions
by: Hend Al-Jaber, et al.
Published: (2025-05-01) -
Self‐Boosting Programmable Release of Multiple Therapeutic Agents by Activatable Heterodimeric Prodrug‐Enzyme Assembly for Antitumor Therapy
by: Shanshan Jiang, et al.
Published: (2025-01-01)